Similarly, Satou et al. [37] reported that the abundance of BCL2 protein within neurons of post-mortem brains from Alzheimer’s disease patients increased with disease severity, suggesting that BCL2 protein may have a protective role at the end-stage of the disease. Here, BCL2 is linked to early-onset autosomal dominant Alzheimer disease.